Skip to content

Conference symposium

ASE 2023 | Dr Pellikka presents Automated Echocardiographic Detection of HFpEF using AI

Background

  • Detection of HFpEF involves integration of multiple imaging and clinical features which are often discordant or indeterminate
  • Hypothesis: Applying artificial intelligence to detect HFpEF from a single apical four-chamber transthoracic echo video clip; accuracy will be better then clinical scores

Methods

  • 3D convolution neural network was developed and rained on A4C video clips
    • HFpEF: diagnosis of HF, EF ≥50%, and echocardiographic evidence of increased filling pressure , n=3785
    • Without HFpEF: No diagnosis of HF, EF ≥50%, normal filling pressure, n=2971
    • Validation holdout 6.8%
  • Softmax activation function to calculate a value 0-1, mapped to HFpEF or no HFpEF; non-diagnostic output generated based on model uncertainty
  • Compared observed sensitivity and specificity in an independent testing data set to average reported in the literature (74% sensitivity, 65% specificity)
  • To demonstrate a 5% increase from the benchmark, and allowing for ~20% nonmagnetic outcomes, 1048 patients were required in an independent testing data set.
  • Multicentre independent retrospective data from Mayo Clinic Health system used for testing.
    • Cases and controls matched for sex and year of echocardiogram and attempts were made to match for age (72.4 yrs vas 4.6 yrs)
    • Up Sampling of non-white and Hispanic populations OT ensure the model would work in a more diverse population.

Results

Testing in 1284 patients

  • Non-diagnostic in 94 (7.3%)  
  • Sensitivity 87.8%
  • Specificity 81.9%
  • During median follow up of 2.3 [0.5-5.6 year] 444(34.6%) patients died
  • Age-adjusted mortality was higher in pts classified as HFpEF by AI

Conclusion

A novel AI HFpEF model based on a single, routinely acquired echocardiographic video demonstrated excellent discrimination of patients with versus without HFpEF, more often than the HFA-PEFF or H2FPEF score and identified patients with higher mortality.

Dr Patrica A. Pellikka

Dr Patrica A. Pellikka

Sign up to hear about the latest news from Ultromics